The use of recombinant factor VIIa in trauma patients.
Talbot
Max
M
1 Canadian Field Hospital, Canadian Forces, Petawawa, ON, Canada.
Tien
Homer C
HC
D001777:Blood Coagulation / Q000187:drug effects; D000075202:Contraindications; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D015942:Factor VIIa / Q000494:pharmacology / Q000627:therapeutic use*; D006470:Hemorrhage / Q000209:etiology* / Q000517:prevention & control*; D006801:Humans; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use; D012307:Risk Factors; D013927:Thrombosis / Q000453:epidemiology; D014947:Wounds and Injuries / Q000150:complications*
D011994:Recombinant Proteins; C103587:recombinant FVIIa; D015942:Factor VIIa